Generated by DeepSeek V3.2| Tisch Cancer Institute | |
|---|---|
| Name | Tisch Cancer Institute |
| Established | 2008 |
| Type | Academic cancer center |
| Affiliation | Icahn School of Medicine at Mount Sinai |
| City | New York City |
| State | New York |
| Country | United States |
Tisch Cancer Institute. It is a National Cancer Institute-designated cancer center located within the Mount Sinai Health System in New York City. Established through a transformative gift from the Tisch family, the institute integrates pioneering research, multidisciplinary clinical care, and advanced education under one umbrella. Its mission is to accelerate the translation of scientific discoveries into innovative treatments for patients.
The institute was formally established in 2008 following a major philanthropic commitment from the Tisch family, prominent supporters of the Mount Sinai Health System. This foundational support enabled the consolidation and expansion of cancer-focused initiatives that had been growing at the Icahn School of Medicine at Mount Sinai for decades. A pivotal milestone was achieved in 2015 when it earned the prestigious designation as a National Cancer Institute Cancer Center, a recognition of its scientific excellence and impact. This designation was successfully renewed in 2022, affirming its continued leadership in the national cancer research landscape.
Research is organized into several focused scientific programs that foster collaboration across disciplines. Key areas of investigation include cancer immunology and immunotherapy, leveraging insights from the immune system to develop novel treatments like checkpoint inhibitors. The institute also has strong programs in cancer genetics and epigenetics, studying the molecular drivers of diseases such as melanoma and glioblastoma. Additional research thrusts encompass experimental therapeutics, where new drug candidates are evaluated, and population science, which studies cancer disparities and outcomes in diverse communities like those in Manhattan and the broader New York City area.
Patients receive care through a fully integrated, multidisciplinary model at facilities including the Mount Sinai Hospital and Mount Sinai West. The institute houses specialized centers of excellence for complex cancers, including the Derald H. Ruttenberg Treatment Center. Clinical teams comprising medical oncologists, surgical oncologists from departments like surgical oncology, and radiation oncologists utilizing advanced technologies develop personalized treatment plans. A strong emphasis is placed on providing access to cutting-edge clinical trials sponsored by organizations like the National Institutes of Health and the Eastern Cooperative Oncology Group.
The institute is deeply integrated into the educational mission of the Icahn School of Medicine at Mount Sinai. It provides extensive training for medical students, residents, and fellows in specialties such as hematology and medical oncology. The American Board of Internal Medicine-accredited fellowship programs train the next generation of physician-scientists. Furthermore, it offers postdoctoral research training and continuing medical education for practicing physicians, often in collaboration with national bodies like the American Society of Clinical Oncology.
The institute is led by a director who oversees its strategic research and clinical priorities. It operates as a core component of the Icahn School of Medicine at Mount Sinai and the broader Mount Sinai Health System. Scientific and clinical leadership is provided by program leaders and disease-specific section chiefs who coordinate activities across the health system's hospitals. This structure ensures tight integration between laboratory research conducted in facilities like the Hess Center for Science and Medicine and patient care delivery.
As an NCI-designated cancer center, it is part of a national network supported by the National Cancer Institute. The institute maintains robust affiliations with other leading centers and cooperative groups, including the National Comprehensive Cancer Network. Its physicians and scientists hold leadership roles in national organizations such as the American Association for Cancer Research. The institute's work is regularly recognized through prestigious awards and competitive grant funding from entities like the National Institutes of Health and the Leukemia & Lymphoma Society.
Category:Cancer centers in the United States Category:Mount Sinai Health System Category:Medical and health organizations based in New York City Category:National Cancer Institute-designated cancer centers